Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Stephen C. Rodriguez"'
While networks have been the standard mathematical representation for detailedarrangements of relations in society, the simplicity of the representation limits whatinformation can be preserved in the abstraction, and subsequently, what can bemathemat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41dc4da9679abf85c6b7616f98476cee
https://osf.io/preprints/socarxiv/kpeuq
https://osf.io/preprints/socarxiv/kpeuq
Autor:
Lian Mao, Stephen C. Rodriguez, Larry Alphs, H. Lynn Starr, Carmela Benson, Jean-Pierre Lindenmayer, Kimberly Cheshire-Kinney
Publikováno v:
The Journal of Clinical Psychiatry. 76:554-561
OBJECTIVE The Paliperidone Palmitate Research in Demonstrating Effectiveness (PRIDE) study compared the effects of once-monthly paliperidone palmitate with daily oral antipsychotics on treatment failure in adults with schizophrenia. METHOD The PRIDE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f04d8b053065a84a158bd7a2f8c284e7
https://doi.org/10.4088/jcp.14m09584
https://doi.org/10.4088/jcp.14m09584
Autor:
David C. Henderson, Stephen C. Rodriguez, Chris Mikesell, Lian Mao, Larry Alphs, Joan Amatniek, Carla M. Canuso, John J. Sheehan, Stephen I. Deutsch
Publikováno v:
Clinical Schizophrenia & Related Psychoses. 8:8-20
Patients with schizophrenia often suffer from comorbid hepatic disease. This multicenter, open-label, single-arm, crossover study evaluated the safety and efficacy of paliperidone extended-release (ER) in patients with schizophrenia or schizoaffectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff03346eb31b4cbd723e3c33f3ae1fe0
https://doi.org/10.3371/csrp.amca.021513
https://doi.org/10.3371/csrp.amca.021513
Publikováno v:
The Journal of clinical psychiatry. 75(12)
Background Public health considerations require that clinical trials address the complex "real-world" needs of patients with chronic illnesses. This is particularly true for persons with schizophrenia, whose management is frequently complicated by fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc863db1674b7ace422d56c0bc5598f
https://pubmed.ncbi.nlm.nih.gov/25375367
https://pubmed.ncbi.nlm.nih.gov/25375367
Autor:
An Jacobs, Joseph Peuskens, Patrick Otten, Lian Mao, Tim Lambert, Cherilyn DeSouza, Concetta Crivera, Wayne Macfadden, José M. Olivares, Kasem Akhras, Stephen C. Rodriguez, Chris M. Kozma, Riad Dirani
Publikováno v:
Annals of General Psychiatry, Vol 10, Iss 1, p 10 (2011)
Annals of General Psychiatry
Annals of General Psychiatry
Background Because wide variations in mental health care utilization exist throughout the world, determining long-term effectiveness of psychotropic medications in a real-world setting would be beneficial to physicians and patients. The purpose of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe78481c30dda3e8246375f6adcbc631
https://doi.org/10.1186/1744-859x-10-10
https://doi.org/10.1186/1744-859x-10-10
Publikováno v:
European Psychiatry. 29:658-659
ObjectifsUn échec de traitement peut entraîner diverses conséquences à la fois pour le patient souffrant de schizophrénie mais aussi en terme de santé publique (arrêt du traitement, hospitalisation, addiction, arrestation/incarcération) [1–
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98bdbb854e89ce30a1cd640e009bba4d
https://doi.org/10.1016/j.eurpsy.2014.09.040
https://doi.org/10.1016/j.eurpsy.2014.09.040
Publikováno v:
Schizophrenia research. 72(2-3)
Maintenance treatment regimens for patients with schizophrenia are often suboptimal. Partial adherence and outright noncompliance are associated with symptom recurrence and increased likelihood of rehospitalization. Long-acting conventional neurolept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89065ec43053ca5d0b4f22e78ec471ba
https://pubmed.ncbi.nlm.nih.gov/15560969
https://pubmed.ncbi.nlm.nih.gov/15560969
Autor:
Gahan Pandina, Ibrahim Turkoz, Andreas Schreiner, Stephen C. Rodriguez, P.D. Harvey, Robert M. Bilder, Mary Kujawa
Publikováno v:
Schizophrenia Research. 98:192
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f592c9b96899166181d0507342ab9fd5
https://doi.org/10.1016/j.schres.2007.12.452
https://doi.org/10.1016/j.schres.2007.12.452
Publikováno v:
Toxicological Sciences. 7:287-292
2-methylresorcinol (2-MR) was administered to groups of 40 male and 35 female Sprague-Dawley rats by admixture with diets at levels of 0.1, 0.4, and 1.5% for periods up to 6 months. Methemoglobin levels were determined after 6 weeks. After 90 days 10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a65760ec7d103b93ec8ceb1bafc33e7a
https://doi.org/10.1093/toxsci/7.2.287
https://doi.org/10.1093/toxsci/7.2.287
Publikováno v:
Toxicological Sciences. 7:293-298
2-Methylresorcinol (2-MR) was administered to groups of 40 male and 35 female Sprague-Dawley rats by admixture with the diets at levels of 0.1, 0.4, and 1.5% (see Part I; T.H. Re, R.F. Loehr, S.C. Rodriguez, C.E. Gilmore, and C.M. Burnett, 1986, Fund
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::127654fefb60b85682864eaf387d5032
https://doi.org/10.1093/toxsci/7.2.293
https://doi.org/10.1093/toxsci/7.2.293